Home >> News >> GlaxoSmithKline (GSK) has appointed Emma Walmsley as new CEO

GlaxoSmithKline (GSK) has appointed Emma Walmsley as new CEO


Global pharma and healthcare firm GSK today announced an appointment of Emma Walmsley as CEO-designate of the company.

Walmsley, currently CEO of GSK’s Consumer Healthcare division, will succeed Andrew Witty when he retires on March 21, 2017, said a statement. She will join the GSK board from January 1 next year, it added.

Prior to this, Walmsley was President of GSK Consumer Healthcare and has been a member of GSK’s Corporate Executive Team since 2011.

Walmsley had joined GSK in 2010 from L’Oreal where, over the course of her 17-year career, she held a variety of marketing and general management positions in the UK, Europe and the US. From 2007, she had been based in Shanghai as General Manager, Consumer Products for L’Oreal China.

Her new pay package will be announced at the start of 2017. With Walmsley’s appointment, seven of the U.K.’s 100 biggest publicly traded companies will have women CEOs.

Leave a Reply

Your email address will not be published. Required fields are marked *